Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, gonorrhea, and chlamydia infections, even if the data ...

It was published on Jan. 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have been skyrocketing, but a new study shows that doxyPEP may be the answer to ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

This is one of the first real-world studies to show the effectiveness of the tactic called doxyPEP, for doxycycline post-exposure prophylaxis, researchers said. Related 20% of people aged 15 to 49 ...

Quarterly syphilis rates decreased from 1.7% prior to doxyPEP availability to 0.3% afterward, while quarterly chlamydia rates declined from 9.6% to 2%. Quarterly gonorrhea infections dropped from 10.2 ...

A study says that taking DoxyPEP reduced the incidence of chlamydia and syphilis by around 80%. DoxyPEP is short for Doxycycline Post-Exposure Prophylaxis. It involves taking a single 200 mg dose ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation." HealthDay News — Doxycycline postexposure ...

It was published on January 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication ...